Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × INDUSTRY × HA 22 × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Hairy Cell 1 Leukemia 1

Interventions

Afatinib 3 niraparib 2 lenvatinib 2 ibrutinib 2 abemaciclib 2 Trastuzumab 2 Gefitinib 2 Capecitabine 2 Abiraterone Acetate 2 3-Iodobenzylguanidine 2 zenocutuzumab 1 vorasidenib 1 tucatinib 1 trilaciclib 1 tovorafenib 1 talquetamab 1 tafasitamab 1 selpercatinib 1 sacituzumab govitecan 1 ripretinib 1 ponatinib 1 pomalidomide 1 pirtobrutinib 1 pertuzumab 1 olaratumab 1 olaparib 1 nilotinib 1 mobocertinib 1 margetuximab 1 lutetium Lu 177 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03501615 2020-06-29

MOXE

AstraZeneca

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡